eMedicine Specialties > Emergency Medicine > Infectious Diseases

Gonorrhea: Differential Diagnoses & Workup

Author: Amy J Behrman, MD, Associate Professor, Department of Emergency Medicine, Director, Division of Occupational Medicine, University of Pennsylvania School of Medicine
Coauthor(s): William H Shoff, MD, DTM&H, Director, PENN Travel Medicine, Associate Professor, Department of Emergency Medicine, Hospital of the University of Pennsylvania
Contributor Information and Disclosures

Updated: Oct 20, 2008

Differential Diagnoses

Chlamydia
Testicular Torsion
Endometriosis
Urinary Tract Infection, Female
Pediatrics, Child Sexual Abuse
Urinary Tract Infection, Male
Pediatrics, Pharyngitis
Vaginitis
Pregnancy, Ectopic
Sexual Assault

Other Problems to Be Considered

Inflammatory arthritis
Septic arthritis
Herpes simplex urethritis
Mucopurulent cervicitis
Nongonococcal conjunctivitis
Nongonococcal endocarditis
Nongonococcal meningitis
Nongonococcal urethritis

Workup

Laboratory Studies

Laboratory studies for suspected gonorrhea may include the following:

  • Gram stain
    • Gram stain is a rapid and inexpensive test available in many EDs.
    • Positive predictive value is high for urethral infection, but a negative Gram stain does not rule out infection in asymptomatic men.
    • Sensitivity and specificity of the Gram stain are lower for endocervical specimens and rectal specimens. Gram stains from these sites are not recommended for routine use in the ED.
    • The test is not useful for the diagnosis of pharyngeal infection because the oropharynx may be colonized by other Neisseria species that can lead to false-positive results. 
  • Culture
    • Specific culture of a swab from the site of infection is a criterion standard for diagnosis at all potential sites of infection and can potentially guide treatment by determining antibiotic susceptibility.
    • N gonorrhoeae is a fastidious organism that requires moist carbon dioxide-rich atmosphere and must be grown on enriched media, usually chocolate agar containing lysed blood.
    • Empiric treatment is often necessary because culture results are not available for 24-48 hours.
    • Cultures are particularly useful when the clinical diagnosis is unclear, when a failure of treatment has occurred, when contact tracing is problematic, and when legal questions arise.
  • Nucleic acid amplification tests
    • Nucleic acid amplification tests (NAATs) are designed to amplify sequences of DNA unique to a given pathogen, such as N gonorrhoeae. These tests are more sensitive and specific than nonamplification techniques.
    • Several FDA-approved NAATs are available for the detection of N gonorrhoeae in urethral swab specimens obtained from males, endocervical swabs, and urine specimens obtained from men and women. These tests are more rapid than culture, more specific than immunoassays, and do not require viable organisms.3
    • NAATs may be of particular use when examination and mucosal swab are difficult (in children or extremely apprehensive patients), and urine specimens are more easily obtained.
    • NAATs can be used on eye secretions, but their performance is less well validated. NAATs are not all recommended for rectal and pharyngeal specimens at this time.
    • Clinicians should be familiar with specimen collection guidelines and performance parameters of the test available at their own hospitals.
  • Suspected DGI
    • When DGI is suspected, blood and joint effusions should be sent for Gram stain and culture, although negative stain results and sterile cultures do not rule out disseminated disease. Cerebrospinal fluid should be stained and cultured if signs or symptoms of meningitis are present.
    • Gram stains, cultures, and/or nucleic acid amplification tests (NAATs) of genital, rectal, conjunctival, and pharyngeal secretions should also be obtained when DGI is suspected, even if the patient has no localized symptoms at any of those sites.
  • Tests to identify other STDs
    • All patients with a likely diagnosis of gonorrheal infection should be tested for syphilis and C trachomatis.
    • Testing for HIV may be indicated. Rapid HIV test technology makes ED testing and referral more practical than enzyme-linked immunosorbent assay (ELISA).
    • Physical examination should always include scrutiny for signs of herpes simplexsyphilis, chancroid, lymphogranuloma venereum, and genital warts.
    • Pregnancy test should always be obtained for women of childbearing age who present with gonorrhea or any other STD.

Imaging Studies

  • Ultrasonography
    • Pelvic ultrasonography or CT scan may demonstrate thick, dilated fallopian tubes or abscess formation.
    • PID is uncommon in pregnancy when the cervical mucous plug may provide some protection to the upper tract. Ultrasonography should be used to rule out ectopic pregnancy whenever a pregnant patient has signs and symptoms of possible PID. See Pregnancy, Ectopic .

Procedures

  • Collect specimens from the urethra, endocervix, pharynx, rectum, conjunctiva, urine, or blood; in addition, perform lumbar puncture and joint aspiration if indicated by clinical findings.
  • Culdocentesis, although rarely indicated, may demonstrate free purulent exudate and provide material for Gram stain and culture.

More on Gonorrhea

Overview: Gonorrhea
Differential Diagnoses & Workup: Gonorrhea
Treatment & Medication: Gonorrhea
Follow-up: Gonorrhea
References

References

  1. CDC. Update to CDC's sexually transmitted diseases treatment guidelines, 2006: fluoroquinolones no longer recommended for treatment of gonococcal infections. MMWR Morb Mortal Wkly Rep. Apr 13 2007;56(14):332-6. [Medline][Full Text].

  2. Goodyear-Smith F. What is the evidence for non-sexual transmission of gonorrhoea in children after the neonatal period? A systematic review. J Forensic Leg Med. Nov 2007;14(8):489-502. [Medline].

  3. Whiley DM, Tapsall JW, Sloots TP. Nucleic acid amplification testing for Neisseria gonorrhoeae: an ongoing challenge. J Mol Diagn. Feb 2006;8(1):3-15. [Medline].

  4. Availability of cefixime 400 mg tablets--United States, April 2008. MMWR Morb Mortal Wkly Rep. Apr 25 2008;57(16):435. [Medline].

  5. Warner L, Stone KM, Macaluso M, et al. Condom use and risk of gonorrhea and Chlamydia: a systematic review of design and measurement factors assessed in epidemiologic studies. Sex Transm Dis. Jan 2006;33(1):36-51. [Medline].

  6. Datta SD, Sternberg M, Johnson RE, et al. Gonorrhea and chlamydia in the United States among persons 14 to 39 years of age, 1999 to 2002. Ann Intern Med. Jul 17 2007;147(2):89-96. [Medline].

  7. MacDonald N, Mailman T, Desai S. Gonococcal infections in newborns and in adolescents. Adv Exp Med Biol. 2008;609:108-30. [Medline].

  8. Ness RB, Smith KJ, Chang CC, et al. Prediction of pelvic inflammatory disease among young, single, sexually active women. Sex Transm Dis. Mar 2006;33(3):137-42. [Medline].

  9. Peeling RW, Holmes KK, Mabey D, et al. Rapid tests for sexually transmitted infections (STIs): the way forward. Sex Transm Infect. Dec 2006;82 Suppl 5:v1-6. [Medline].

  10. Peter NG, Clark LR, Jaeger JR. Fitz-Hugh-Curtis syndrome: a diagnosis to consider in women with right upper quadrant pain. Cleve Clin J Med. Mar 2004;71(3):233-9. [Medline].

  11. Ross JD. Systemic gonococcal infection. Genitourin Med. Dec 1996;72(6):404-7. [Medline].

  12. Spigarelli MG. Urine gonococcal/Chlamydia testing in adolescents. Curr Opin Obstet Gynecol. Oct 2006;18(5):498-502. [Medline].

  13. Thompson EC, Brantley D. Gonoccocal endocarditis. J Natl Med Assoc. Jun 1996;88(6):353-6. [Medline].

  14. Workowski KA, Berman SM. Sexually transmitted diseases treatment guidelines, 2006. MMWR Recomm Rep. Aug 4 2006;55:1-94. [Medline][Full Text].

  15. Workowski KA, Berman SM, Douglas JM Jr. Emerging antimicrobial resistance in Neisseria gonorrhoeae: urgent need to strengthen prevention strategies. Ann Intern Med. Apr 15 2008;148(8):606-13. [Medline].

Further Reading

Contributor Information and Disclosures

Author

Amy J Behrman, MD, Associate Professor, Department of Emergency Medicine, Director, Division of Occupational Medicine, University of Pennsylvania School of Medicine
Amy J Behrman, MD is a member of the following medical societies: American College of Occupational and Environmental Medicine
Disclosure: Nothing to disclose.

Coauthor(s)

William H Shoff, MD, DTM&H, Director, PENN Travel Medicine, Associate Professor, Department of Emergency Medicine, Hospital of the University of Pennsylvania
William H Shoff, MD, DTM&H is a member of the following medical societies: American College of Physicians, American Society of Tropical Medicine and Hygiene, International Society of Travel Medicine, Society for Academic Emergency Medicine, and Wilderness Medical Society
Disclosure: Glaxo Smith Kline Consulting fee Consulting; Glaxo Smith Kline Honoraria Speaking and teaching

Medical Editor

Edward A Michelson, MD, Program Director, Associate Professor, Department of Emergency Medicine, University Hospital Health Systems in Cleveland
Edward A Michelson, MD is a member of the following medical societies: American College of Emergency Physicians, National Association of EMS Physicians, and Society for Academic Emergency Medicine
Disclosure: Nothing to disclose.

Pharmacy Editor

Francisco Talavera, PharmD, PhD, Senior Pharmacy Editor, eMedicine
Disclosure: Nothing to disclose.

Managing Editor

Barry J Sheridan, DO, Chief, Department of Emergency Medical Services, Brooke Army Medical Center
Barry J Sheridan, DO is a member of the following medical societies: American Academy of Emergency Medicine
Disclosure: Nothing to disclose.

CME Editor

John D Halamka, MD, MS, Associate Professor of Medicine, Harvard Medical School, Beth Israel Deaconess Medical Center; Chief Information Officer, CareGroup Healthcare System and Harvard Medical School; Attending Physician, Division of Emergency Medicine, Beth Israel Deaconess Medical Center
John D Halamka, MD, MS is a member of the following medical societies: American College of Emergency Physicians, American Medical Informatics Association, Phi Beta Kappa, and Society for Academic Emergency Medicine
Disclosure: Nothing to disclose.

Chief Editor

Steven C Dronen, MD, FAAEM, Director of Emergency Services, Director of Chest Pain Center, Department of Emergency Medicine, Ft Sanders Sevier Medical Center
Steven C Dronen, MD, FAAEM is a member of the following medical societies: American Academy of Emergency Medicine and Society for Academic Emergency Medicine
Disclosure: Nothing to disclose.

 
 
HONcode

We subscribe to the
HONcode principles of the
Health On the Net Foundation

All material on this website is protected by copyright, Copyright© 1994- by Medscape.
This website also contains material copyrighted by 3rd parties.

DISCLAIMER: The content of this Website is not influenced by sponsors. The site is designed primarily for use by qualified physicians and other medical professionals. The information contained herein should NOT be used as a substitute for the advice of an appropriately qualified and licensed physician or other health care provider. The information provided here is for educational and informational purposes only. In no way should it be considered as offering medical advice. Please check with a physician if you suspect you are ill.